Ana Cristina Gales

· Universidade Federal de São Paulo
62h 指数
21,660总引用
393发文
230i10

简介

Ana Cristina Gales is Professor at the Division of Infectious Diseases, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM-UNIFESP), and Director of the Laboratory Alerta at the same institution. She received her medical degree from the Faculdade de Medicina FUABC (1991), and continued her residency training in Internal Medicine and Infectious Diseases (1992-1995) at the EPM-UNIFESP, São Paulo, Brazil. She finished her PhD in Health Sciences at EPM-UNIFESP (2001) after completing her research fellowship in Medical Microbiology at the Department of Pathology, University of Iowa, Iowa City, USA (1998-2000). Dr. Gales’ research has been focused on the molecular epidemiology of multidrug-resistant bacteria and in vitro activity of new antimicrobials. She has authored more than 240 publications in peer-reviewed journals, accumulating more than 9,900 citations (H index 51) up to April, 2021, according to data provided by Scopus. Dr. Gales is a full member of the Technical Chamber on Microbial Resistance in Health Services (CATREM), with the purpose of advising the Brazilian Health Surveillance Agency (ANVISA) in establishing standards and measures for monitoring, control, and prevention of antimicrobial resistance in Brazilian health services. She has also collaborated with several worldwide programs to monitor antimicrobial resistance rates and phenotypes among clinically relevant pathogens and served as Chair of the Brazilian Committee on Antimicrobial Susceptibility (BrCAST, 2017-2018). She is also an associate editor for mSphere®, The Brazilian Journal of Infectious Diseases, and the Journal of Global Antimicrobial Resistance.

研究方向

Antibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyAntibiotic Use and ResistanceBacterial Identification and Susceptibility TestingVibrio bacteria research studies

数据来源: OpenAlex + ORCID + Wikidata · 数据质量: verified

登录后开启学术探索

收藏教授 / 论文 / 学科排名, 订阅研究方向更新。登录后开启这些能力。

已有账号?